EUVIMEDOtkrijte EUVIMED
Open access · CC BY 4.0

Proteoglycan inhibition of canonical BMP-dependent cartilage maturation delays endochondral ossification

Elham Koosha, Connor T A Brenna iD, Amir M Ashique iD, Niteesh Jain, Katie Ovens, Toshiyasu Koike, Hiroshi Kitagawa iD, B Frank Eames iD

Development · 2024

DOI: 10.1242/dev.201716 ↗

At a glance

Journal article in Development, 2024. Written by Elham Koosha and 7 co-authors. Institution: Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada. Major MEDLINE topics: Osteogenesis, Proteoglycans. Cited 9 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY 4.0). Funded by: CIHR, Saskatchewan Health Research Foundation, Canadian Institutes of Health Research.

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

During endochondral ossification, chondrocytes secrete a proteoglycan (PG)-rich extracellular matrix that can inhibit the process of cartilage maturation, including expression of Ihh and Col10a1. Because bone morphogenetic proteins (BMPs) can promote cartilage maturation, we hypothesized that cartilage PGs normally inhibit BMP signalling. Accordingly, BMP signalling was evaluated in chondrocytes of wild-type and PG mutant (fam20b−/−) zebrafish and inhibited with temporal control using the drug DMH1 or an inducible dominant-negative BMP receptor transgene (dnBMPR). Compared with wild type, phospho-Smad1/5/9, but not phospho-p38, was increased in fam20b−/− chondrocytes, but only after they secreted PGs. Phospho-Smad1/5/9 was decreased in DMH1-treated or dnBMPR-activated wild-type chondrocytes, and DMH1 also decreased phospho-p38 levels. ihha and col10a1a were decreased in DMH1-treated or dnBMPR-activated chondrocytes, and less perichondral bone formed. Finally, early ihha and col10a1a expression and early perichondral bone formation of fam20b mutants were rescued with DMH1 treatment or dnBMPR activation. Therefore, PG inhibition of canonical BMP-dependent cartilage maturation delays endochondral ossification, and these results offer hope for the development of growth factor therapies for skeletal defects of PG diseases.

Subjects

MeSH terms (MEDLINE)

OsteogenesisProteoglycansAnimalsZebrafishCartilageChondrocytesBone Morphogenetic Proteins

Author keywords

BMP signallingCartilage maturationDevelopmental timingEndochondral ossificationProteoglycansZebrafish

Substances

ProteoglycansBone Morphogenetic Proteins

Authors and institutions

  • Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
  • Department of Computer Science, University of Calgary, Calgary, AB T2N 1N4, Canada.
  • Department of Biochemistry, Kobe Pharmaceutical University, Higashinada-ku, Kobe 658-0003, Japan.

ORCID profiles: Connor T A Brenna, Amir M Ashique, Hiroshi Kitagawa, B Frank Eames

Funding

  • CIHR
  • Saskatchewan Health Research Foundation
  • Canadian Institutes of Health Research
  • University of Saskatchewan

Cite

APA

Koosha, E., Brenna, C. T. A., Ashique, A. M., Jain, N., Ovens, K., Koike, T., Kitagawa, H., & Eames, B. F. (2024). Proteoglycan inhibition of canonical BMP-dependent cartilage maturation delays endochondral ossification. Development. https://doi.org/10.1242/dev.201716

Vancouver

Koosha E, Brenna CTA, Ashique AM, Jain N, Ovens K, Koike T, et al. Proteoglycan inhibition of canonical BMP-dependent cartilage maturation delays endochondral ossification. Development. 2024. doi:10.1242/dev.201716

BibTeX
@article{Koosha2024,
  author = {Koosha, Elham and Brenna, Connor T A and Ashique, Amir M and Jain, Niteesh and Ovens, Katie and Koike, Toshiyasu and Kitagawa, Hiroshi and Eames, B Frank},
  title = {Proteoglycan inhibition of canonical BMP-dependent cartilage maturation delays endochondral ossification},
  journal = {Development},
  year = {2024},
  doi = {10.1242/dev.201716}
}
Start for free →